(MAIN) Main Street Capital - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US56035L1044
Stock: Private Equity, Mezzanine Debt, Senior Debt, Subordinated Debt, Preferred Equity
Total Rating 29
Risk 61
Buy Signal -1.62
| Risk 5d forecast | |
|---|---|
| Volatility | 24.9% |
| Relative Tail Risk | 0.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -7.12 |
| Character TTM | |
|---|---|
| Beta | 0.812 |
| Beta Downside | 0.919 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.97% |
| CAGR/Max DD | 1.17 |
EPS (Earnings per Share)
Revenue
Description: MAIN Main Street Capital January 09, 2026
Main Street Capital Corporation (NYSE: MAIN) is a publicly traded business development company that focuses on providing both private equity and private debt financing to lower-middle-market companies. It makes direct equity investments-ranging from control to non-control stakes-and offers a suite of debt solutions (senior secured, mezzanine, subordinated, and preferred equity) to support recapitalizations, growth capital, M&A, and refinancing across a broad industry spectrum.
As of the latest filing, MAIN reported $5.0 billion in total assets under management and generated a 7.2 % dividend yield, reflecting its BDC mandate to return cash to shareholders. The firm’s portfolio is weighted heavily toward logistics, industrial equipment, and health-care services-sectors that have benefited from post-pandemic supply-chain reshoring and rising demand for specialty medical devices. However, its performance remains sensitive to credit-cycle dynamics and interest-rate movements, which can affect both the cost of capital for borrowers and the valuation of its debt holdings.
For a deeper quantitative dive into MAIN’s valuation metrics and risk profile, you might find ValueRay’s analyst tools useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 536.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 9.54 > 1.0 |
| NWC/Revenue: -1.44% < 20% (prev 19.20%; Δ -20.64% < -1%) |
| CFO/TA 0.07 > 3% & CFO 396.0m > Net Income 536.5m |
| Net Debt (2.12b) to EBITDA (554.8m): 3.82 < 3 |
| Current Ratio: 0.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (89.2m) vs 12m ago 1.99% < -2% |
| Gross Margin: 82.71% > 18% (prev 0.83%; Δ 8188 % > 0.5%) |
| Asset Turnover: 14.51% > 50% (prev 13.37%; Δ 1.15% > 0%) |
| Interest Coverage Ratio: 5.07 > 6 (EBITDA TTM 554.8m / Interest Expense TTM 130.2m) |
Altman Z'' 1.36
| A: -0.00 (Total Current Assets 30.6m - Total Current Liabilities 41.4m) / Total Assets 5.28b |
| B: 0.09 (Retained Earnings 481.7m / Total Assets 5.28b) |
| C: 0.13 (EBIT TTM 660.6m / Avg Total Assets 5.19b) |
| D: 0.21 (Book Value of Equity 482.6m / Total Liabilities 2.35b) |
| Altman-Z'' Score: 1.36 = BB |
Beneish M
| DSRI: 1.03 (Receivables 98.1m/86.4m, Revenue 753.1m/681.0m) |
| GMI: 1.01 (GM 82.71% / 83.29%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.11 (Revenue 753.1m / 681.0m) |
| TATA: 0.03 (NI 536.5m - CFO 396.0m) / TA 5.28b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of MAIN shares?
As of February 18, 2026, the stock is trading at USD 59.18 with a total of 590,450 shares traded.
Over the past week, the price has changed by -4.64%, over one month by -5.85%, over three months by +5.47% and over the past year by +2.37%.
Over the past week, the price has changed by -4.64%, over one month by -5.85%, over three months by +5.47% and over the past year by +2.37%.
Is MAIN a buy, sell or hold?
Main Street Capital has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold MAIN.
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MAIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.4 | 7.2% |
| Analysts Target Price | 63.4 | 7.2% |
MAIN Fundamental Data Overview February 15, 2026
P/E Trailing = 10.0746
P/E Forward = 15.528
P/S = 9.4872
P/B = 1.8589
P/EG = 2.09
Revenue TTM = 753.1m USD
EBIT TTM = 660.6m USD
EBITDA TTM = 554.8m USD
Long Term Debt = unknown (none)
Short Term Debt = 151.1m USD (from shortTermDebt, last fiscal year)
Debt = 2.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.12b USD (from netDebt column, last quarter)
Enterprise Value = 7.44b USD (5.33b + Debt 2.15b - CCE 30.6m)
Interest Coverage Ratio = 5.07 (Ebit TTM 660.6m / Interest Expense TTM 130.2m)
EV/FCF = 18.80x (Enterprise Value 7.44b / FCF TTM 396.0m)
FCF Yield = 5.32% (FCF TTM 396.0m / Enterprise Value 7.44b)
FCF Margin = 52.58% (FCF TTM 396.0m / Revenue TTM 753.1m)
Net Margin = 71.24% (Net Income TTM 536.5m / Revenue TTM 753.1m)
Gross Margin = 82.71% ((Revenue TTM 753.1m - Cost of Revenue TTM 130.2m) / Revenue TTM)
Gross Margin QoQ = 82.32% (prev 81.67%)
Tobins Q-Ratio = 1.41 (Enterprise Value 7.44b / Total Assets 5.28b)
Interest Expense / Debt = 1.51% (Interest Expense 32.5m / Debt 2.15b)
Taxrate = 7.29% (9.72m / 133.4m)
NOPAT = 612.5m (EBIT 660.6m * (1 - 7.29%))
Current Ratio = 0.74 (Total Current Assets 30.6m / Total Current Liabilities 41.4m)
Debt / Equity = 0.73 (Debt 2.15b / totalStockholderEquity, last quarter 2.93b)
Debt / EBITDA = 3.82 (Net Debt 2.12b / EBITDA 554.8m)
Debt / FCF = 5.35 (Net Debt 2.12b / FCF TTM 396.0m)
Total Stockholder Equity = 2.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.34% (Net Income 536.5m / Total Assets 5.28b)
RoE = 18.73% (Net Income TTM 536.5m / Total Stockholder Equity 2.86b)
RoCE = 12.60% (EBIT 660.6m / Capital Employed (Total Assets 5.28b - Current Liab 41.4m))
RoIC = 12.13% (NOPAT 612.5m / Invested Capital 5.05b)
WACC = 6.75% (E(5.33b)/V(7.47b) * Re(8.91%) + D(2.15b)/V(7.47b) * Rd(1.51%) * (1-Tc(0.07)))
Discount Rate = 8.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.78%
[DCF Debug] Terminal Value 76.29% ; FCFF base≈396.0m ; Y1≈259.9m ; Y5≈118.6m
Fair Price DCF = 9.80 (EV 3.00b - Net Debt 2.12b = Equity 877.9m / Shares 89.6m; r=6.75% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -9.92 | EPS CAGR: -42.99% | SUE: -4.0 | # QB: 0
Revenue Correlation: 71.05 | Revenue CAGR: 8.46% | SUE: 0.80 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=+0.008 | Revisions Net=+2 | Analysts=8
EPS next Year (2026-12-31): EPS=3.95 | Chg30d=+0.048 | Revisions Net=+2 | Growth EPS=-0.2% | Growth Revenue=+2.6%
P/E Forward = 15.528
P/S = 9.4872
P/B = 1.8589
P/EG = 2.09
Revenue TTM = 753.1m USD
EBIT TTM = 660.6m USD
EBITDA TTM = 554.8m USD
Long Term Debt = unknown (none)
Short Term Debt = 151.1m USD (from shortTermDebt, last fiscal year)
Debt = 2.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.12b USD (from netDebt column, last quarter)
Enterprise Value = 7.44b USD (5.33b + Debt 2.15b - CCE 30.6m)
Interest Coverage Ratio = 5.07 (Ebit TTM 660.6m / Interest Expense TTM 130.2m)
EV/FCF = 18.80x (Enterprise Value 7.44b / FCF TTM 396.0m)
FCF Yield = 5.32% (FCF TTM 396.0m / Enterprise Value 7.44b)
FCF Margin = 52.58% (FCF TTM 396.0m / Revenue TTM 753.1m)
Net Margin = 71.24% (Net Income TTM 536.5m / Revenue TTM 753.1m)
Gross Margin = 82.71% ((Revenue TTM 753.1m - Cost of Revenue TTM 130.2m) / Revenue TTM)
Gross Margin QoQ = 82.32% (prev 81.67%)
Tobins Q-Ratio = 1.41 (Enterprise Value 7.44b / Total Assets 5.28b)
Interest Expense / Debt = 1.51% (Interest Expense 32.5m / Debt 2.15b)
Taxrate = 7.29% (9.72m / 133.4m)
NOPAT = 612.5m (EBIT 660.6m * (1 - 7.29%))
Current Ratio = 0.74 (Total Current Assets 30.6m / Total Current Liabilities 41.4m)
Debt / Equity = 0.73 (Debt 2.15b / totalStockholderEquity, last quarter 2.93b)
Debt / EBITDA = 3.82 (Net Debt 2.12b / EBITDA 554.8m)
Debt / FCF = 5.35 (Net Debt 2.12b / FCF TTM 396.0m)
Total Stockholder Equity = 2.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.34% (Net Income 536.5m / Total Assets 5.28b)
RoE = 18.73% (Net Income TTM 536.5m / Total Stockholder Equity 2.86b)
RoCE = 12.60% (EBIT 660.6m / Capital Employed (Total Assets 5.28b - Current Liab 41.4m))
RoIC = 12.13% (NOPAT 612.5m / Invested Capital 5.05b)
WACC = 6.75% (E(5.33b)/V(7.47b) * Re(8.91%) + D(2.15b)/V(7.47b) * Rd(1.51%) * (1-Tc(0.07)))
Discount Rate = 8.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.78%
[DCF Debug] Terminal Value 76.29% ; FCFF base≈396.0m ; Y1≈259.9m ; Y5≈118.6m
Fair Price DCF = 9.80 (EV 3.00b - Net Debt 2.12b = Equity 877.9m / Shares 89.6m; r=6.75% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -9.92 | EPS CAGR: -42.99% | SUE: -4.0 | # QB: 0
Revenue Correlation: 71.05 | Revenue CAGR: 8.46% | SUE: 0.80 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=+0.008 | Revisions Net=+2 | Analysts=8
EPS next Year (2026-12-31): EPS=3.95 | Chg30d=+0.048 | Revisions Net=+2 | Growth EPS=-0.2% | Growth Revenue=+2.6%